Výsledky vyhledávání - "Vladimir Valera"

Akademický článek

Molecular sub-classification of renal epithelial tumors using meta-analysis of gene expression microarrays.

Autor: Thomas Sanford, Paul H Chung, Ariel Reinish, Vladimir Valera, Ramaprasad Srinivasan, W Marston Linehan, Gennady Bratslavsky

Publikováno v: PLoS ONE, Vol 6, Iss 7, p e21260 (2011)

PurposeTo evaluate the accuracy of the sub-classification of renal cortical neoplasms using molecular signatures.Experimental designA search of publicly available databases was performed to identify microarray datasets with multiple histologic sub-ty

Externí odkaz: https://doaj.org/article/983b3e973d3d441883991b2b66369602

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Supplementary Data from Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

Supplementary Data from Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91fac2839c0f806f56fe1cbb014c15e7
https://doi.org/10.1158/1078-0432.22486583.v1

Zobrazit plný text záznamu

Data from Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

Purpose:This study investigated the efficacy and tolerability of cabozantinib plus nivolumab (CaboNivo) in patients with metastatic urothelial carcinoma (mUC) that progressed on checkpoint inhibition (CPI).Patients and Methods:A phase I expansion coh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35680e61fde6720351d13f1d7642bf4a
https://doi.org/10.1158/1078-0432.c.6532346

Zobrazit plný text záznamu

Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

Publikováno v: Clinical Cancer Research. 28:1353-1362

Purpose: This study investigated the efficacy and tolerability of cabozantinib plus nivolumab (CaboNivo) in patients with metastatic urothelial carcinoma (mUC) that progressed on checkpoint inhibition (CPI). Patients and Methods: A phase I expansion

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a052a8ee13fc91996589c4bbfe769d83
https://doi.org/10.1158/1078-0432.ccr-21-3726

Zobrazit plný text záznamu

Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors

Publikováno v: Journal of Clinical Oncology

PURPOSE We assessed the safety and efficacy of cabozantinib and nivolumab (CaboNivo) and CaboNivo plus ipilimumab (CaboNivoIpi) in patients with metastatic urothelial carcinoma (mUC) and other genitourinary (GU) malignances. PATIENTS AND METHODS Pati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57aa8802a4543aa052b3e2026f87d0a8
https://doi.org/10.1200/jco.20.01652

Zobrazit plný text záznamu

microRNA Expression Profiling in Young Prostate Cancer Patients

Autor: Vladimir Valera, Peter A. Pinto, Maria J. Merino, Rafael Parra-Medina, Beatriz A. Walter

Publikováno v: Journal of Cancer
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario

MicroRNAs (miRNAs) are small, non-coding RNA molecules with multiple roles in many biological processes. Few studies have shown the molecular characteristics in younger prostate cancer (PCa) patients. In this study, we performed miRNA profiling in yo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6df00215fc944058d799b72ea592c058
https://doi.org/10.7150/jca.37842

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání